AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.27B |
| 2 |
Visa
V
|
+$459M |
| 3 |
Nike
NKE
|
+$410M |
| 4 |
Etsy
ETSY
|
+$311M |
| 5 |
Gen Digital
GEN
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$606M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$492M |
| 3 |
Procter & Gamble
PG
|
+$389M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$310M |
| 5 |
IQVIA
IQV
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.23% |
| 2 | Healthcare | 14.38% |
| 3 | Consumer Discretionary | 13.88% |
| 4 | Financials | 12.81% |
| 5 | Communication Services | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Arlo Technologies
ARLO
$1.6B
| $424K | ﹤0.01% |
62,700
| – | – |
|
2877
Liquidity Services
LQDT
$1.22B
| $424K | ﹤0.01% |
16,660
+3,300
| +25% | +$72.6K |
|
2878
Motorcar Parts of America
MPAA
$254M
| $424K | ﹤0.01% |
18,910
-1,400
| -7% | -$31.8K |
|
|
KZR
2879
DELISTED
Kezar Life Sciences
KZR
| $422K | ﹤0.01% |
7,770
+150
| +2% | +$8.52K |
|
|
APPH
2880
DELISTED
AppHarvest, Inc. Common Stock
APPH
| $422K | ﹤0.01% |
+26,400
| New | +$421K |
|
2881
Black Diamond Therapeutics
BDTX
$96.8M
| $421K | ﹤0.01% |
34,500
+19,600
| +132% | +$387K |
|
|
TRTX
2882
TPG RE Finance Trust
TRTX
$612M
| $421K | ﹤0.01% |
31,300
-3,600
| -10% | -$46.1K |
|
|
JNCE
2883
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $421K | ﹤0.01% |
61,900
+6,000
| +11% | +$49.8K |
|
|
BRSP
2884
BrightSpire Capital
BRSP
$634M
| $420K | ﹤0.01% |
44,660
-5,753
| -11% | -$53K |
|
2885
EverQuote
EVER
$892M
| $418K | ﹤0.01% |
12,800
+1,700
| +15% | +$56.7K |
|
2886
RB Global
RBA
$20.4B
| $418K | ﹤0.01% |
7,051
-56
| -0.8% | -$3.45K |
|
2887
Phathom Pharmaceuticals
PHAT
$708M
| $416K | ﹤0.01% |
12,300
+1,800
| +17% | +$64.5K |
|
2888
Seneca Foods Class A
SENEA
$1.12B
| $416K | ﹤0.01% |
8,150
-100
| -1% | -$4.83K |
|
2889
Harmony Biosciences
HRMY
$2.04B
| $415K | ﹤0.01% |
+14,700
| New | +$441K |
|
2890
Weis Markets
WMK
$1.91B
| $415K | ﹤0.01% |
8,025
+1,200
| +18% | +$63.6K |
|
|
BDSI
2891
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $415K | ﹤0.01% |
116,000
+6,000
| +5% | +$21.2K |
|
2892
Universal Electronics
UEIC
$57.8M
| $414K | ﹤0.01% |
8,540
-2,260
| -21% | -$117K |
|
|
AWH
2893
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $413K | ﹤0.01% |
4,900
+547
| +13% | +$47K |
|
2894
Green Brick Partners
GRBK
$3.04B
| $412K | ﹤0.01% |
+18,100
| New | +$434K |
|
2895
Cytosorbents Corp
CTSO
$22.7M
| $411K | ﹤0.01% |
54,500
+2,200
| +4% | +$18.5K |
|
2896
Inseego
INSG
$114M
| $410K | ﹤0.01% |
4,065
-2,367
| -37% | -$216K |
|
2897
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.7B
| $409K | ﹤0.01% |
5,050
+219
| +5% | +$17.6K |
|
2898
Anterix
ATEX
$1.81B
| $408K | ﹤0.01% |
6,800
-61,884
| -90% | -$3.1M |
|
|
BFS
2899
Saul Centers
BFS
$836M
| $402K | ﹤0.01% |
8,847
-700
| -7% | -$30.4K |
|
2900
Q32 Bio
QTTB
$466M
| $402K | ﹤0.01% |
3,072
+644
| +27% | +$80.4K |
|
Similar funds
AllianceBernstein's Q2 2021 Portfolio in Review
As of Q2 2021, AllianceBernstein held 3,558 positions worth $249B, up 9.2% from $228B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
AllianceBernstein's Q2 2021 filing shows 327 new, 1,436 increased, 1,300 reduced and 241 closed positions. Its largest new stake was Coinbase: 547,649 shares worth $139M. The largest sale was Regeneron Pharmaceuticals, an estimated $606M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- AllianceBernstein's largest Q2 2021 buy was Coinbase: 547,649 shares worth $139M.
- AllianceBernstein added most to Amazon in Q2 2021, an estimated $1.27B increase.
- AllianceBernstein's biggest Q2 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $606M.
- AllianceBernstein fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $43.3M.
- AllianceBernstein's ten largest holdings make up 24% of its $249B portfolio in Q2 2021.
- AllianceBernstein opened 327 new positions and closed 241 in Q2 2021.
- AllianceBernstein's portfolio value rose 9.2% quarter-over-quarter to $249B.
Based on AllianceBernstein's 13F filing for Q2 2021, filed 30 Jul 2021.